Calico (company)
Search results
Utilizing advanced computational biology, microbial genomics, and ultra-deep sequencing, we construct proprietary data clouds to elucidate host-microbe interactions and provide unparalleled insight into the microbiome’s role in human health.
Seed develops clinically-studied probiotics to impact human and planetary health. Our first product is the DS-01® Daily Synbiotic—a probiotic + prebiotic for systemic benefits.
Seed Health is a microbiome science company pioneering applications of microbes for human and planetary health. In collaboration with leading academic researchers, we advance breakthrough...
Us. Our founding scientists have assembled a collective of practitioners, designers, engineers, bioinformaticians, operators, and scientific communicators, all working collaboratively to redefine human health and foster a more symbiotic coexistence with our natural world.
The science of probiotics demands precision. In collaboration with leading scientists and research partners from around the world, we develop research-backed probiotics for outcomes across gastrointestinal, dermatological, oral, pediatric, and nutritional health. For humans, by science.
Apr 21, 2021 · LOS ANGELES, April 21, 2021 /PRNewswire/ -- Seed Health, a microbial sciences company developing next-generation probiotic applications and live biotherapeutics, today announced the close of a...
Apr 11, 2024 · Seed Health became profitable by selling consumer probiotics, and now it's chasing much bigger science, investing in an AI platform for microbiome moonshots.
Apr 21, 2021 · Seed Health is a microbial sciences company pioneering applications of microbes for human and planetary health. In collaboration with leading academic researchers, we advance breakthrough ...
Apr 11, 2024 · Seed Health today launched CODA, a computational biology platform for the discovery and development of next-generation precision probiotics and microbiome-directed interventions.
Seed Health Closes $40 Million in Series A Financing to Launch New Categories, Accelerate Global Distribution and Expand Clinical Research. 2021.
